The lung-gut crosstalk in respiratory and inflammatory bowel disease
- PMID: 37680747
- PMCID: PMC10482113
- DOI: 10.3389/fcimb.2023.1218565
The lung-gut crosstalk in respiratory and inflammatory bowel disease
Abstract
Both lung and gut belong to the common mucosal immune system (CMIS), with huge surface areas exposed to the external environment. They are the main defense organs against the invasion of pathogens and play a key role in innate and adaptive immunity. Recently, more and more evidence showed that stimulation of one organ can affect the other, as exemplified by intestinal complications during respiratory disease and vice versa, which is called lung-gut crosstalk. Intestinal microbiota plays an important role in respiratory and intestinal diseases. It is known that intestinal microbial imbalance is related to inflammatory bowel disease (IBD), this imbalance could impact the integrity of the intestinal epithelial barrier and leads to the persistence of inflammation, however, gut microbial disturbances have also been observed in respiratory diseases such as asthma, allergy, chronic obstructive pulmonary disease (COPD), and respiratory infection. It is not fully clarified how these disorders happened. In this review, we summarized the latest examples and possible mechanisms of lung-gut crosstalk in respiratory disease and IBD and discussed the strategy of shaping intestinal flora to treat respiratory diseases.
Keywords: common mucosal immune system; inflammatory bowel disease; lung-gut crosstalk; microbiota; respiratory disease.
Copyright © 2023 Du, Fu, Han, Sun, Xu, Yang and Rong.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.Front Immunol. 2020 Sep 11;11:2144. doi: 10.3389/fimmu.2020.02144. eCollection 2020. Front Immunol. 2020. PMID: 33042125 Free PMC article. Review.
-
Gut-lung crosstalk in pulmonary involvement with inflammatory bowel diseases.World J Gastroenterol. 2013 Oct 28;19(40):6794-804. doi: 10.3748/wjg.v19.i40.6794. World J Gastroenterol. 2013. PMID: 24187454 Free PMC article. Review.
-
Gut-lung Microbiota Interactions in Chronic Obstructive Pulmonary Disease (COPD): Potential Mechanisms Driving Progression to COPD and Epidemiological Data.Lung. 2022 Dec;200(6):773-781. doi: 10.1007/s00408-022-00581-8. Epub 2022 Oct 14. Lung. 2022. PMID: 36241745 Review.
-
Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?J Gastroenterol Hepatol. 2022 Sep;37(9):1710-1718. doi: 10.1111/jgh.15970. Epub 2022 Aug 5. J Gastroenterol Hepatol. 2022. PMID: 35906780 Review.
-
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.Dan Med J. 2015 Jan;62(1):B4973. Dan Med J. 2015. PMID: 25557335 Review.
Cited by
-
Targeted nuclear degranulation of neutrophils promotes the progression of pneumonia in ulcerative colitis.Precis Clin Med. 2024 Oct 14;7(4):pbae028. doi: 10.1093/pcmedi/pbae028. eCollection 2024 Dec. Precis Clin Med. 2024. PMID: 39540022 Free PMC article.
-
Host Transcriptional Regulatory Genes and Microbiome Networks Crosstalk through Immune Receptors Establishing Normal and Tumor Multiomics Metafirm of the Oral-Gut-Lung Axis.Int J Mol Sci. 2023 Nov 23;24(23):16638. doi: 10.3390/ijms242316638. Int J Mol Sci. 2023. PMID: 38068961 Free PMC article. Review.
References
-
- Adams S. M., Close E. D., Shreenath A. P. (2022). Ulcerative colitis: rapid evidence review. Am. Family Physician 105, 406–411. - PubMed